Cargando…

α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma

Eosinophilic inflammation is one of the main pathophysiological features in asthma. Two subtypes of eosinophils exist in the lung and systemic circulation: lung-resident eosinophils (rEOS) and inflammatory eosinophils (iEOS). We evaluated the expression of α(4)β(1) and α(M)β(2) integrins of eosinoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurkeviciute, Egle, Januskevicius, Andrius, Rimkunas, Airidas, Palacionyte, Jolita, Malakauskas, Kestutis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467456/
https://www.ncbi.nlm.nih.gov/pubmed/34575607
http://dx.doi.org/10.3390/jpm11090829
_version_ 1784573402394132480
author Jurkeviciute, Egle
Januskevicius, Andrius
Rimkunas, Airidas
Palacionyte, Jolita
Malakauskas, Kestutis
author_facet Jurkeviciute, Egle
Januskevicius, Andrius
Rimkunas, Airidas
Palacionyte, Jolita
Malakauskas, Kestutis
author_sort Jurkeviciute, Egle
collection PubMed
description Eosinophilic inflammation is one of the main pathophysiological features in asthma. Two subtypes of eosinophils exist in the lung and systemic circulation: lung-resident eosinophils (rEOS) and inflammatory eosinophils (iEOS). We evaluated the expression of α(4)β(1) and α(M)β(2) integrins of eosinophil subtypes and their influence on airway smooth muscle (ASM) cell proliferation and viability in asthma. We included 16 severe non-allergic eosinophilic asthma (SNEA) patients, 13 steroid-free, non-severe allergic asthma (AA) patients, and 12 healthy control subjects (HS). For AA patients, a bronchial allergen challenge with Dermatophagoides pteronyssinus was performed. The eosinophil subtypes were distinguished using magnetic bead-labeled antibodies against surface CD62L, and individual combined cell cultures were prepared with ASM cells. The integrins gene expression was analyzed by a quantitative real-time polymerase chain reaction. Proliferation was assessed by the Alamar blue assay, and viability by annexin V and propidium iodide staining. rEOS-like cells were characterized by the relatively higher gene expression of the β(1) integrin subunit, whereas iEOS-like cells were characterized by the α(M) and β(2) integrin subunits. The inclusion of either eosinophil subtypes in co-culture significantly increased the proliferation of ASM cells, and the effect of rEOS-like cells was stronger than iEOS-like cells (p < 0.05). Furthermore, rEOS-like cells had a more pronounced effect on reducing ASM cell apoptosis compared to that of iEOS-like cells (p < 0.05). Lastly, the bronchial allergen challenge significantly enhanced only the iEOS-like cells’ effect on ASM cell proliferation and viability in AA patients (p < 0.05). These findings highlight the different expression of α(4)β(1) and α(M)β(2) integrins on distinct eosinophil subtypes in asthma. Therefore, rEOS-like cells have a stronger effect in stimulating ASM cell proliferation and viability; however, contact with specific allergens mainly enhances pro-proliferative iEOS-like cell properties.
format Online
Article
Text
id pubmed-8467456
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84674562021-09-27 α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma Jurkeviciute, Egle Januskevicius, Andrius Rimkunas, Airidas Palacionyte, Jolita Malakauskas, Kestutis J Pers Med Article Eosinophilic inflammation is one of the main pathophysiological features in asthma. Two subtypes of eosinophils exist in the lung and systemic circulation: lung-resident eosinophils (rEOS) and inflammatory eosinophils (iEOS). We evaluated the expression of α(4)β(1) and α(M)β(2) integrins of eosinophil subtypes and their influence on airway smooth muscle (ASM) cell proliferation and viability in asthma. We included 16 severe non-allergic eosinophilic asthma (SNEA) patients, 13 steroid-free, non-severe allergic asthma (AA) patients, and 12 healthy control subjects (HS). For AA patients, a bronchial allergen challenge with Dermatophagoides pteronyssinus was performed. The eosinophil subtypes were distinguished using magnetic bead-labeled antibodies against surface CD62L, and individual combined cell cultures were prepared with ASM cells. The integrins gene expression was analyzed by a quantitative real-time polymerase chain reaction. Proliferation was assessed by the Alamar blue assay, and viability by annexin V and propidium iodide staining. rEOS-like cells were characterized by the relatively higher gene expression of the β(1) integrin subunit, whereas iEOS-like cells were characterized by the α(M) and β(2) integrin subunits. The inclusion of either eosinophil subtypes in co-culture significantly increased the proliferation of ASM cells, and the effect of rEOS-like cells was stronger than iEOS-like cells (p < 0.05). Furthermore, rEOS-like cells had a more pronounced effect on reducing ASM cell apoptosis compared to that of iEOS-like cells (p < 0.05). Lastly, the bronchial allergen challenge significantly enhanced only the iEOS-like cells’ effect on ASM cell proliferation and viability in AA patients (p < 0.05). These findings highlight the different expression of α(4)β(1) and α(M)β(2) integrins on distinct eosinophil subtypes in asthma. Therefore, rEOS-like cells have a stronger effect in stimulating ASM cell proliferation and viability; however, contact with specific allergens mainly enhances pro-proliferative iEOS-like cell properties. MDPI 2021-08-24 /pmc/articles/PMC8467456/ /pubmed/34575607 http://dx.doi.org/10.3390/jpm11090829 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jurkeviciute, Egle
Januskevicius, Andrius
Rimkunas, Airidas
Palacionyte, Jolita
Malakauskas, Kestutis
α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title_full α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title_fullStr α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title_full_unstemmed α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title_short α(4)β(1) and α(M)β(2) Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
title_sort α(4)β(1) and α(m)β(2) integrin expression and pro-proliferative properties of eosinophil subtypes in asthma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467456/
https://www.ncbi.nlm.nih.gov/pubmed/34575607
http://dx.doi.org/10.3390/jpm11090829
work_keys_str_mv AT jurkeviciuteegle a4b1andamb2integrinexpressionandproproliferativepropertiesofeosinophilsubtypesinasthma
AT januskeviciusandrius a4b1andamb2integrinexpressionandproproliferativepropertiesofeosinophilsubtypesinasthma
AT rimkunasairidas a4b1andamb2integrinexpressionandproproliferativepropertiesofeosinophilsubtypesinasthma
AT palacionytejolita a4b1andamb2integrinexpressionandproproliferativepropertiesofeosinophilsubtypesinasthma
AT malakauskaskestutis a4b1andamb2integrinexpressionandproproliferativepropertiesofeosinophilsubtypesinasthma